Does the media prefer PAYC or CLBT?

In the previous week, Paycom Software had 17 more articles in the media than Cellebrite DI. MarketBeat recorded 24 mentions for Paycom Software and 7 mentions for Cellebrite DI. Paycom Software's average media sentiment score of 0.65 beat Cellebrite DI's score of 0.63 indicating that Paycom Software is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Paycom Software 8 Very Positive mention(s) 4 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Cellebrite DI 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CLBT or BSY?

In the previous week, Bentley Systems had 35 more articles in the media than Cellebrite DI. MarketBeat recorded 42 mentions for Bentley Systems and 7 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 0.63 beat Bentley Systems' score of 0.57 indicating that Cellebrite DI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cellebrite DI 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Bentley Systems 9 Very Positive mention(s) 9 Positive mention(s) 17 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings & valuation, CLBT or ESTC?

Elastic has higher revenue and earnings than Cellebrite DI. Elastic is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cellebrite DI $475.67M 6.66 $78.33M $0.22 57.73 Elastic $1.74B 5.28 $367.77M $3.57 24.48

Is CLBT or ESTC more profitable?

Elastic has a net margin of 20.84% compared to Cellebrite DI's net margin of 11.43%. Cellebrite DI's return on equity of 15.58% beat Elastic's return on equity. Company Net Margins Return on Equity Return on Assets Cellebrite DI 11.43% 15.58% 8.29% Elastic 20.84% -0.35% -0.14%

Does the media refer more to CLBT or ESTC?

In the previous week, Cellebrite DI had 1 more articles in the media than Elastic. MarketBeat recorded 7 mentions for Cellebrite DI and 6 mentions for Elastic. Cellebrite DI's average media sentiment score of 0.63 beat Elastic's score of 0.36 indicating that Cellebrite DI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cellebrite DI 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elastic 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Is FIG or CLBT more profitable?

Cellebrite DI has a net margin of 11.43% compared to Figma's net margin of -40.21%. Cellebrite DI's return on equity of 15.58% beat Figma's return on equity. Company Net Margins Return on Equity Return on Assets Figma -40.21% -32.80% -20.72% Cellebrite DI 11.43% 15.58% 8.29%

Does the media favor FIG or CLBT?

In the previous week, Figma had 21 more articles in the media than Cellebrite DI. MarketBeat recorded 28 mentions for Figma and 7 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 0.63 beat Figma's score of 0.31 indicating that Cellebrite DI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Figma 8 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Cellebrite DI 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, CLBT or IREN?

Cellebrite DI has higher earnings, but lower revenue than IREN. IREN is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cellebrite DI $475.67M 6.66 $78.33M $0.22 57.73 IREN $707.01M 11.62 -$702.62M -$4.08 N/A

Is CLBT or IREN more profitable?

Cellebrite DI has a net margin of 11.43% compared to IREN's net margin of -194.36%. Cellebrite DI's return on equity of 15.58% beat IREN's return on equity. Company Net Margins Return on Equity Return on Assets Cellebrite DI 11.43% 15.58% 8.29% IREN -194.36% -16.36% -4.67%

Does the media favor CLBT or IREN?

In the previous week, IREN had 99 more articles in the media than Cellebrite DI. MarketBeat recorded 106 mentions for IREN and 7 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 0.63 beat IREN's score of 0.03 indicating that Cellebrite DI is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cellebrite DI 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IREN 19 Very Positive mention(s) 24 Positive mention(s) 22 Neutral mention(s) 24 Negative mention(s) 7 Very Negative mention(s) Neutral

Live Earnings Conference Call: Cellebrite DI will host a live Q3 2026 earnings call on November 12, 2026 at 8:30AM ET. Get details.

Cellebrite DI (CLBT) Competitors

$12.70 +0.06 (+0.47%)

Closing price 11/11/2026 04:00 PM Eastern

Extended Trading

$13.64 +0.94 (+7.36%)

As of 08:02 AM Eastern

Compare

CLBT vs. PAYC, BSY, ESTC, FIG, and IREN

Should you buy Cellebrite DI stock or one of its competitors? Cellebrite DI's main competitors and comparable companies include Paycom Software (PAYC), Bentley Systems (BSY), Elastic (ESTC), Figma (FIG), and IREN (IREN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "application software" industry.

How does Cellebrite DI compare to Paycom Software?

Paycom Software (NYSE:PAYC) and Cellebrite DI (NASDAQ:CLBT) are both technology companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

Paycom Software has a beta of 0.75, suggesting that its stock price is 25% less volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market.

Paycom Software has a net margin of 23.28% compared to Cellebrite DI's net margin of 11.43%. Paycom Software's return on equity of 52.12% beat Cellebrite DI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Paycom Software	23.28%	52.12%	8.40%
Cellebrite DI	11.43%	15.58%	8.29%

Paycom Software has higher revenue and earnings than Cellebrite DI. Paycom Software is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Paycom Software	$2.05B	5.33	$453.40M	$10.44	23.25
Cellebrite DI	$475.67M	6.66	$78.33M	$0.22	57.73

Paycom Software currently has a consensus price target of $255.36, suggesting a potential upside of 5.22%. Cellebrite DI has a consensus price target of $16.70, suggesting a potential upside of 31.50%. Given Cellebrite DI's stronger consensus rating and higher possible upside, analysts clearly believe Cellebrite DI is more favorable than Paycom Software.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Paycom Software	1 Sell rating(s)	12 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.18
Cellebrite DI	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

87.8% of Paycom Software shares are held by institutional investors. Comparatively, 45.9% of Cellebrite DI shares are held by institutional investors. 13.2% of Paycom Software shares are held by insiders. Comparatively, 5.7% of Cellebrite DI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Paycom Software had 17 more articles in the media than Cellebrite DI. MarketBeat recorded 24 mentions for Paycom Software and 7 mentions for Cellebrite DI. Paycom Software's average media sentiment score of 0.65 beat Cellebrite DI's score of 0.63 indicating that Paycom Software is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Paycom Software	8 Very Positive mention(s)	4 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Cellebrite DI	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Paycom Software beats Cellebrite DI on 10 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to Bentley Systems?

Cellebrite DI (NASDAQ:CLBT) and Bentley Systems (NASDAQ:BSY) are both technology companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk.

Bentley Systems has a net margin of 19.57% compared to Cellebrite DI's net margin of 11.43%. Bentley Systems' return on equity of 29.99% beat Cellebrite DI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cellebrite DI	11.43%	15.58%	8.29%
Bentley Systems	19.57%	29.99%	10.33%

Bentley Systems has higher revenue and earnings than Cellebrite DI. Bentley Systems is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cellebrite DI	$475.67M	6.66	$78.33M	$0.22	57.73
Bentley Systems	$1.65B	7.85	$277.86M	$1.02	43.57

Cellebrite DI has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market. Comparatively, Bentley Systems has a beta of 0.98, suggesting that its share price is 2% less volatile than the broader market.

Cellebrite DI currently has a consensus price target of $16.70, suggesting a potential upside of 31.50%. Bentley Systems has a consensus price target of $46.67, suggesting a potential upside of 5.01%. Given Cellebrite DI's higher probable upside, equities research analysts plainly believe Cellebrite DI is more favorable than Bentley Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cellebrite DI	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Bentley Systems	0 Sell rating(s)	4 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.69

45.9% of Cellebrite DI shares are held by institutional investors. Comparatively, 44.2% of Bentley Systems shares are held by institutional investors. 5.7% of Cellebrite DI shares are held by insiders. Comparatively, 20.3% of Bentley Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Bentley Systems had 35 more articles in the media than Cellebrite DI. MarketBeat recorded 42 mentions for Bentley Systems and 7 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 0.63 beat Bentley Systems' score of 0.57 indicating that Cellebrite DI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cellebrite DI	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Bentley Systems	9 Very Positive mention(s)	9 Positive mention(s)	17 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Bentley Systems beats Cellebrite DI on 11 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to Elastic?

Cellebrite DI (NASDAQ:CLBT) and Elastic (NYSE:ESTC) are both mid-cap technology companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, valuation, analyst recommendations, profitability, earnings and risk.

Cellebrite DI currently has a consensus price target of $16.70, indicating a potential upside of 31.50%. Elastic has a consensus price target of $98.56, indicating a potential upside of 12.76%. Given Cellebrite DI's stronger consensus rating and higher possible upside, equities analysts plainly believe Cellebrite DI is more favorable than Elastic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cellebrite DI	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
Elastic	0 Sell rating(s)	13 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.57

Elastic has a net margin of 20.84% compared to Cellebrite DI's net margin of 11.43%. Cellebrite DI's return on equity of 15.58% beat Elastic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cellebrite DI	11.43%	15.58%	8.29%
Elastic	20.84%	-0.35%	-0.14%

Elastic has higher revenue and earnings than Cellebrite DI. Elastic is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cellebrite DI	$475.67M	6.66	$78.33M	$0.22	57.73
Elastic	$1.74B	5.28	$367.77M	$3.57	24.48

In the previous week, Cellebrite DI had 1 more articles in the media than Elastic. MarketBeat recorded 7 mentions for Cellebrite DI and 6 mentions for Elastic. Cellebrite DI's average media sentiment score of 0.63 beat Elastic's score of 0.36 indicating that Cellebrite DI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cellebrite DI	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elastic	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cellebrite DI has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market. Comparatively, Elastic has a beta of 0.97, suggesting that its share price is 3% less volatile than the broader market.

45.9% of Cellebrite DI shares are held by institutional investors. Comparatively, 97.0% of Elastic shares are held by institutional investors. 5.7% of Cellebrite DI shares are held by insiders. Comparatively, 12.7% of Elastic shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Cellebrite DI beats Elastic on 9 of the 16 factors compared between the two stocks.

How does Cellebrite DI compare to Figma?

Figma (NYSE:FIG) and Cellebrite DI (NASDAQ:CLBT) are both mid-cap technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability and risk.

Figma presently has a consensus target price of $28.80, indicating a potential upside of 51.66%. Cellebrite DI has a consensus target price of $16.70, indicating a potential upside of 31.50%. Given Figma's higher probable upside, analysts clearly believe Figma is more favorable than Cellebrite DI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Figma	1 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.19
Cellebrite DI	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67

Cellebrite DI has lower revenue, but higher earnings than Figma. Figma is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Figma	$1.06B	8.23	-$1.25B	-$1.07	N/A
Cellebrite DI	$475.67M	6.66	$78.33M	$0.22	57.73

In the previous week, Figma had 21 more articles in the media than Cellebrite DI. MarketBeat recorded 28 mentions for Figma and 7 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 0.63 beat Figma's score of 0.31 indicating that Cellebrite DI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Figma	8 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cellebrite DI	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

45.9% of Cellebrite DI shares are held by institutional investors. 32.3% of Figma shares are held by company insiders. Comparatively, 5.7% of Cellebrite DI shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Figma has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market. Comparatively, Cellebrite DI has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market.

Cellebrite DI has a net margin of 11.43% compared to Figma's net margin of -40.21%. Cellebrite DI's return on equity of 15.58% beat Figma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Figma	-40.21%	-32.80%	-20.72%
Cellebrite DI	11.43%	15.58%	8.29%

Summary

Cellebrite DI beats Figma on 9 of the 15 factors compared between the two stocks.

How does Cellebrite DI compare to IREN?

Cellebrite DI (NASDAQ:CLBT) and IREN (NASDAQ:IREN) are both mid-cap technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Cellebrite DI has a net margin of 11.43% compared to IREN's net margin of -194.36%. Cellebrite DI's return on equity of 15.58% beat IREN's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cellebrite DI	11.43%	15.58%	8.29%
IREN	-194.36%	-16.36%	-4.67%

45.9% of Cellebrite DI shares are owned by institutional investors. Comparatively, 41.1% of IREN shares are owned by institutional investors. 5.7% of Cellebrite DI shares are owned by company insiders. Comparatively, 6.9% of IREN shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Cellebrite DI has higher earnings, but lower revenue than IREN. IREN is trading at a lower price-to-earnings ratio than Cellebrite DI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cellebrite DI	$475.67M	6.66	$78.33M	$0.22	57.73
IREN	$707.01M	11.62	-$702.62M	-$4.08	N/A

In the previous week, IREN had 99 more articles in the media than Cellebrite DI. MarketBeat recorded 106 mentions for IREN and 7 mentions for Cellebrite DI. Cellebrite DI's average media sentiment score of 0.63 beat IREN's score of 0.03 indicating that Cellebrite DI is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cellebrite DI	1 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IREN	19 Very Positive mention(s)	24 Positive mention(s)	22 Neutral mention(s)	24 Negative mention(s)	7 Very Negative mention(s)	Neutral

Cellebrite DI currently has a consensus price target of $16.70, indicating a potential upside of 31.50%. IREN has a consensus price target of $64.57, indicating a potential upside of 209.84%. Given IREN's stronger consensus rating and higher probable upside, analysts clearly believe IREN is more favorable than Cellebrite DI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cellebrite DI	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.67
IREN	1 Sell rating(s)	5 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.73

Cellebrite DI has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market. Comparatively, IREN has a beta of 4.33, indicating that its stock price is 333% more volatile than the broader market.

Summary

IREN beats Cellebrite DI on 9 of the 17 factors compared between the two stocks.

Get Cellebrite DI News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CLBT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CLBT vs. The Competition

Export

Metric	Cellebrite DI	Software Industry	Technology Sector	NASDAQ Exchange
Market Cap	$3.17B	$15.79B	$26.77B	$12.04B
Dividend Yield	N/A	3.39%	2.90%	4.46%
P/E Ratio	57.73	49.32	44.96	30.76
Price / Sales	6.16	5.79	5.41	5.47
Price / Cash	31.28	27.74	27.04	22.51
Price / Book	6.29	6.16	5.38	3.80
Net Income	$78.33M	$424.69M	$786.79M	$390.43M
7 Day Performance	2.58%	2.39%	5.35%	3.40%
1 Month Performance	11.01%	-2.62%	-6.27%	-5.36%
1 Year Performance	-20.48%	-11.06%	2.30%	-5.91%

Cellebrite DI Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CLBT Cellebrite DI	4.4284 of 5 stars	$12.70 +0.5%	$16.70 +31.5%	-19.1%	$3.17B	$514.29M	57.73	1,285	Options Volume
PAYC Paycom Software	4.1398 of 5 stars	$265.66 +0.6%	$256.21 -3.6%	+42.6%	$11.84B	$2.05B	28.23	5,770
BSY Bentley Systems	3.2325 of 5 stars	$42.40 +3.7%	$44.77 +5.6%	-1.2%	$11.46B	$1.50B	46.59	7,900	Earnings Report Insider Trade
ESTC Elastic	3.9282 of 5 stars	$91.48 -6.0%	$98.56 +7.7%	-7.7%	$11.19B	$1.74B	25.62	4,019	Upcoming Earnings Analyst Downgrade Gap Up
FIG Figma	3.6498 of 5 stars	$22.16 +2.4%	$30.50 +37.6%	-57.3%	$9.85B	$1.28B	N/A	1,886	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CLBT) was last updated on 11/12/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cellebrite DI (CLBT) Competitors

CLBT vs. PAYC, BSY, ESTC, FIG, and IREN

How does Cellebrite DI compare to Paycom Software?

Summary

How does Cellebrite DI compare to Bentley Systems?

Summary

How does Cellebrite DI compare to Elastic?

Summary

How does Cellebrite DI compare to Figma?

Summary

How does Cellebrite DI compare to IREN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLBT vs. The Competition

Cellebrite DI Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cellebrite DI (CLBT) Competitors

CLBT vs. PAYC, BSY, ESTC, FIG, and IREN

How does Cellebrite DI compare to Paycom Software?

Which has more volatility and risk, PAYC or CLBT?

Is PAYC or CLBT more profitable?

Which has preferable valuation & earnings, PAYC or CLBT?

Do analysts recommend PAYC or CLBT?

Do institutionals and insiders hold more shares of PAYC or CLBT?

Does the media prefer PAYC or CLBT?

Summary

How does Cellebrite DI compare to Bentley Systems?

Is CLBT or BSY more profitable?

Which has preferable valuation & earnings, CLBT or BSY?

Which has more risk & volatility, CLBT or BSY?

Do analysts prefer CLBT or BSY?

Do institutionals & insiders hold more shares of CLBT or BSY?

Does the media favor CLBT or BSY?

Summary

How does Cellebrite DI compare to Elastic?

Do analysts recommend CLBT or ESTC?

Is CLBT or ESTC more profitable?

Which has preferable earnings & valuation, CLBT or ESTC?

Does the media refer more to CLBT or ESTC?

Which has more volatility & risk, CLBT or ESTC?

Do insiders and institutionals have more ownership in CLBT or ESTC?

Summary

How does Cellebrite DI compare to Figma?

Do analysts prefer FIG or CLBT?

Which has preferable earnings & valuation, FIG or CLBT?

Does the media favor FIG or CLBT?

Do insiders and institutionals believe in FIG or CLBT?

Which has more volatility and risk, FIG or CLBT?

Is FIG or CLBT more profitable?

Summary

How does Cellebrite DI compare to IREN?

Is CLBT or IREN more profitable?

Do insiders & institutionals believe in CLBT or IREN?

Which has better valuation and earnings, CLBT or IREN?

Does the media favor CLBT or IREN?

Do analysts recommend CLBT or IREN?

Which has more risk and volatility, CLBT or IREN?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CLBT vs. The Competition

Cellebrite DI Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools